11th October 2024
Author orrbitt3453906
11th October 2024
Biotech startups Upstream and CAMP4 price Friday IPOs
1st October 2024
CAMP4, BioMarin ink research deal for genetic disease targets
17th April 2024
Turning science into business: Amplifying mRNA by targeting regRNAs
21st February 2024
Sizing up induced microglia-like cells as neurodegenerative disease models: a Q&A with Gokul Ramaswami, Ph.D.
7th August 2023
Unlocking the Potential of RegRNAs
26th April 2023
New therapies offer hope for patients with rare genetic conditions
3rd August 2022